[Home]
[Full version]
Biological electron transfer captured in real time
Mar 03 ,General Science
Two research teams led by Dr. Michael Verkhovsky and Prof. Mårten Wikström of the Institute of Biotechnology of the University of Helsinki have for the first time succeeded in monitoring electron transfer by Complex I in real time. In the future, this work might, for example, have medical relevance, because most of the maternally inherited so-called mitochondrial diseases are caused by dysfunction of Complex I.
This achievement required developing and building of a special device by which the enzyme-catalysed electron transfer could be captured at different time points by stopping the reaction at liquid nitrogen temperatures, on a microsecond (one millionth of a second) time scale. The electrons are very small elementary particles, which is why their transfer is very fast. This work is published this week in PNAS. The results give certain hints of the function of Complex I at the molecular level.
Electron transfer is central to many chemical reactions in the cell. It has particular functional importance in cell respiration, which in eukaryotes takes place in the inner mitochondrial membrane, and in the cell membrane of prokaryotes. In cellular respiration molecules stemming from food are oxidised to carbon dioxide, and the electrons liberated in the process are "fed" into the so-called respiratory chain, which consists of three successive membrane-bound enzyme complexes, finally to react with the oxygen we breathe, which is reduced to water using these electrons.
The purpose of electron transfer in cellular respiration is to release the major part of the energy of foodstuffs and to conserve it in a suitable form, ATP (adenosine triphosphate), which the cell may use in its energy-requiring reactions (e.g. biosynthesis, active transport, mechanical work), which are essential e.g. during fetal development and growth, in neural and kidney function, muscle contraction, etc.
The energy captured in cellular respiration is transduced to ATP in two phases. The role of the respiratory chain is to couple electron transfer to the translocation of positively charged protons across the membrane, so that the mitochondrial membrane (or the cell membrane in bacteria) becomes electrically polarised, just like charging up a battery. In the second phase, the voltage difference of the battery is used to drive the protons back across the membrane, coupled to the synthesis of ATP by very special molecular machinery.
The first enzyme complex of the respiratory chain is called Complex I. High-energy electrons are fed into this complex in the form of a reduced coenzyme, NADH (nicotinamide adenine dinucleotide), which is oxidised to NAD+ having donated its two electrons. After this, the electrons are transferred along several protein-bound iron/sulphur centres in Complex I until they reach their destination, a molecule of ubiquinone, which is thus reduced to ubiquinol. This reaction, as catalysed by Complex I, is linked to proton translocation across the membrane and thus leads to "charging the battery". At a later stage ubiquinol donates its electrons further in the respiratory chain (ultimately to oxygen), by which it is oxidised back to ubiquinone to allow continuation of Complex I function.
Source: University of Helsinki
Related stories:
Stretchable silicon camera next step to artificial retina
(PhysOrg.com) -- By combining stretchable optoelectronics and biologically inspired design, scientists have created a remarkable imaging device, with a layout based on the human eye.
A single VSOP can do a 'proton' magic!
International research group led by Yasushi Okamura, a professor in Japanese National Institute for Physiological Sciences, Okazaki, and Peter Larsson, a professor in Oregon Health & Science University, Oregon, US, found that a single protein of VSOP, Voltage Sensor Only Protein/ Hv1, can carry protons even without making a multimeric complex.
Dominant cholesterol-metabolism ideas challenged by new research
A team of researchers investigating cholesterol and lipid transport has performed experiments that cast serious doubt on the dominant hypothesis of how the body rids its cells of "bad" cholesterol (LDL) and increases "good" cholesterol (HDL). Cholesterol metabolism is an area of intense inquiry because high levels of LDL cholesterol or total cholesterol put about half of all Americans at significant risk of heart disease.
New, nanoporous ceramic filter offers hope to kidney-dialysis patients
If you are one of the 370,000 Americans who lack functioning kidneys, you are all too familiar with the exhausting procedure of kidney dialysis. Three or four times every week, you visit a special clinic and sit for four hours as your blood is removed, cleaned and returned to your body.
Hairstyle of a Neuron: From Hairy to Mushroom-Head
Synapses are essential for the brain's normal function: their absence or presence is tightly linked to the brain's ability to transfer, process, and store information. Synapses are thus constantly generated and degraded. However, the mechanisms of this complex remodelling process remained largely unknown. Scientists of the Max Planck Institute of Neurobiology have now identified the molecular players involved in synapse formation.
Physicists pioneer new super-thin technology (Update)
Researchers have used the world's thinnest material to create a new type of technology, which could be used to make super-fast electronic components and speed up the development of drugs.
Complex channels
The messages passed in a neuronal network can target something like 100 billion nerve cells in the brain alone. These, in turn communicate with millions of other cells and organs in the body. How, then, do whole cascades of events trigger responses that are highly specific, quick and precisely timed? A team at the Weizmann Institute of Science (Israel) has now shed light on this mysterious mechanism.
Novel approach to cancer drug given major boost
Scientists at the ProXara Biotechnology Limited have identified a way of switching off one of the key mechanisms that leads to the development and growth of a tumour. Under the Wellcome Trust's Seeding Drug Discovery initiative, the researchers hope to use their findings to develop a drug which could be used to fight cancer. The funding will be used to develop the drug to a point at which it is close to entering a clinical trial.
[Home]
[Full version]